Cargando…

Mizoribine as a safe and effective combined maintenance therapy with prednisolone for anti-neutrophil cytoplasmic antibody-associated vasculitis in a hemodialysis patient

A 77-year-old man developed severe renal insufficiency due to proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA)-associated vasculitis, and was started on hemodialysis (HD). Because his renal insufficiency appeared to be irreversible, he was maintained on oral prednisolone (PSL) at 5 mg/da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Gen, Homma, Noriyuki, Sakamaki, Yuichi, Toyama, Mio, Unno, Megumi, Kuroda, Takeshi, Narita, Ichiei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418497/ https://www.ncbi.nlm.nih.gov/pubmed/28509286 http://dx.doi.org/10.1007/s13730-012-0050-1

Ejemplares similares

A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange
por: Ikeda, Yuki, et al.
Publicado: (2019)

The Efficacy of Mizoribine (Inosine Monophosphate Dehydrogenase Inhibitor) for ANCA-Associated Vasculitis with Hepatitis B Virus Carrier
por: Muratsu, Jun, et al.
Publicado: (2012)

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome
por: Saito, Takao, et al.
Publicado: (2016)

Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)
por: Hama, Taketsugu, et al.
Publicado: (2018)

Mizoribine: A New Approach in the Treatment of Renal Disease
por: Kawasaki, Yukihiko
Publicado: (2009)

Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics
por: Murakami, Teruo, et al.
Publicado: (2012)

Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis
por: Tsuchida, Yohei, et al.
Publicado: (2013)

Granulomatosis with polyangiitis diagnosed during the treatment of otitis media with prednisolone in a patient with anti-neutrophil cytoplasmic antibody-associated vasculitis: A case report
por: Tokuyasu, Hirokazu, et al.
Publicado: (2022)

The Immunosuppressive Agent Mizoribine Monophosphate Is an Inhibitor of the Human RNA Capping Enzyme
por: Picard-Jean, Frédéric, et al.
Publicado: (2013)

Evaluation of Mizoribine as an Immunosuppressant in Subrenal Capsule Assay Using Immunocompetent Mice
por: Chen, Dong‐Yi, et al.
Publicado: (1990)

In Vitro and in Vivo Antiviral Activity of Mizoribine Against Foot-And-Mouth Disease Virus
por: Li, Shi-Fang, et al.
Publicado: (2019)

Mizoribine treatment in an elderly diabetic patient with antisynthetase-associated interstitial lung disease
por: Nagai, Kei, et al.
Publicado: (2020)

Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine
por: Nishikawa, Sho, et al.
Publicado: (2022)

Long-term post-marketing surveillance of mizoribine for the treatment of lupus nephritis: Safety and efficacy during a 3-year follow-up
por: Yagi, Nobuyuki, et al.
Publicado: (2014)

Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with vasculitis of rheumatic disease
por: Rouster-Stevens, KA, et al.
Publicado: (2005)

Effects of Biologic Agents in Patients with Rheumatoid Arthritis and Amyloidosis Treated with Hemodialysis
por: Kuroda, Takeshi, et al.
Publicado: (2016)

Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine
por: Kaneko, Tomohiro, et al.
Publicado: (2015)

Nitazoxanide protects cats from feline calicivirus infection and acts synergistically with mizoribine in vitro
por: Cui, Zhanding, et al.
Publicado: (2020)

Influence of cyclosporine A on glomerular growth and the effect of mizoribine and losartan on cyclosporine nephrotoxicity in young rats
por: Kim, Ji Hong, et al.
Publicado: (2016)

Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus
por: Saijo, Masayuki, et al.
Publicado: (2005)

Chronic Portal-Systemic Shunt Encephalopathy in a Hemodialysis Patient Treated with Balloon-Occluded Retrograde Transvenous Obliteration
por: Yasukawa, Ryota, et al.
Publicado: (2013)

Efficacy of tacrolimus as maintenance therapy after cyclophosphamide for treating antineutrophil cytoplasmic antibody-associated vasculitis
por: Pyo, Jung Yoon, et al.
Publicado: (2021)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
por: Hellmark, Thomas, et al.
Publicado: (2019)

Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Sun, Xiao-Jing, et al.
Publicado: (2023)

Recovery of intracranial stenoses in varicella zoster virus vasculitis after long-term treatment with valacyclovir and prednisolone
por: Kraemer, Markus, et al.
Publicado: (2022)

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
por: Michailidou, Despina, et al.
Publicado: (2022)

Suspicion Is Key: Diagnosing Elusive Cytoplasmic Antineutrophil Cytoplasmic Antibody (c-ANCA)-Positive Vasculitis
por: Crowe, Timothy P, et al.
Publicado: (2022)

Long-term Clinical Course of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Patients off Maintenance Therapy
por: Gapud, Eric J, et al.
Publicado: (2018)

A Meta-Analysis of the Safety and Efficacy of Maintenance Therapies for Antineutrophil Cytoplasmic Antibody Small-Vessel Vasculitis
por: Bellos, Ioannis, et al.
Publicado: (2022)

Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech
por: Suzuki, Minami, et al.
Publicado: (2022)

Lifetime and age-conditional risk estimates of end-stage kidney disease requiring maintenance dialysis in Japan
por: Wakasugi, Minako, et al.
Publicado: (2020)

A Ruptured Jejunal Arterial Aneurysm in a Young Woman Undergoing Chronic Hemodialysis Due to Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Murakawa, Masataka, et al.
Publicado: (2021)

Exploratory classification of clinical phenotypes in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis using cluster analysis
por: Watanabe, Haruki, et al.
Publicado: (2021)

Testicular granulomatous vasculitis mimicking testicular torsion in an anti-neutrophil cytoplasmic antibody–associated vasculitis patient
por: Suo, Liye, et al.
Publicado: (2019)

Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis
por: Yoon, Taejun, et al.
Publicado: (2020)

Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function
por: Kaneko, Tomohiro, et al.
Publicado: (2010)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
por: Shikha, Deep, et al.
Publicado: (2015)

Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Lazarus, B., et al.
Publicado: (2016)

Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Golemati, Christina V., et al.
Publicado: (2017)

The role of mycophenolate in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis
por: Koukoulaki, Maria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6j4dlni6lkl8me6vdvhv3i5is6